Skip to main content
SpringerLink
Log in

Zur klinischen Bedeutung von Betalaktamase-Inhibitoren

  • Pharmakologika: Neues Aus Klinik Und Forschung Der Arzneitherapie
  • Published:
Klinische Wochenschrift Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur

  1. Abraham EP, Chain E (1940) Nature 146:837

    Google Scholar 

  2. Abraham EP, Newton GGG (1956) Biochemical J 63:628–634

    Google Scholar 

  3. Aronoff SC (1984) AAC 26:580–582

    Google Scholar 

  4. Aronoff SC et al. (1986) JAC 18:271–276

    Google Scholar 

  5. Basker MJ (1982) JAC 10:4–7

    Google Scholar 

  6. Bush K, Freudenberger JS, Sykes RB (1982) AAC 22:414–420

    Google Scholar 

  7. Butterworth D, Cole M, Hanscomb G, Rolinson GN (1979) J Antibiotics 32:287–294

    Google Scholar 

  8. Cartwright SJ, Waley SG (1983) Med Res Rev 3:341–382

    Google Scholar 

  9. Charnas RL, Knowles JR (1981) Biochemistry 20:3214–3219

    Google Scholar 

  10. Chin NX, Neu HC (1987) 27th ICAAC, Abstr. 1209

  11. Cohen SA, Pratt RF (1980) Biochemistry 19:3996–4003

    Google Scholar 

  12. Cole M (1980) Phil Trans R Soc London B 289:207–223

    Google Scholar 

  13. English AR et al. (1978) AAC 14:414–419

    Google Scholar 

  14. Fisher J, Charnas RL, Bradley SM, Knowles JW (1981) Biochemistry 20:2726–2731

    Google Scholar 

  15. Gledhill L et al. (1987) 27th ICAAC, Abstr. 1206

  16. Grace ME et al. (1987) 27th ICAAC, Abstr. 1211

  17. Hamilton-Miller JMT, Smith JT (1964) Nature 201:999–1001

    Google Scholar 

  18. Higashitani F et al. (1987) 27th ICAAC, Abstr. 1207

  19. Howarth TT, Brown AG, King TJ (1976) J Chem Soc Chem Commun 1976:266–267

    Google Scholar 

  20. Kitzis MD et al. (1987) 27th ICAAC, Abstr. 1208

  21. Kuck NA et al. (1987) 27th ICAAC, Abstr. 1210

  22. Labia R, Lelievre V, Peduzzi J (1980) Biochem Biophys Acta 611:351–353

    Google Scholar 

  23. Moosdeen F, Yamabe S, Williams J (1983) 1st European Congress of Clinical Microbiology Bologna

  24. O'Callaghan CH, Morris A (1972) AAC 2:442–448

    Google Scholar 

  25. Piot P, van Dyck E (1985) JAC 16:808–809

    Google Scholar 

  26. Pratt RF, Loosemore MJ (1978) Proc Natl Acad Sci USA 75:4145–4149

    Google Scholar 

  27. Reading C, Cole M (1977) AAC 11:852–857

    Google Scholar 

  28. Richmond MH (1981) JAC 7:279–285

    Google Scholar 

  29. Roholt I, Keiding J (1987) 15th ICC, Abstr. 296

  30. Rolinson GN et al. (1960) Lancet II:564–567

    Google Scholar 

  31. Stapley EO et al. (1977) 17th ICAAC, New York

  32. Then RL (1981) Chemotherapy 27 (Suppl 1): 25–31

    Google Scholar 

  33. Yamaguchi A et al. (1985) J Antibiotics 38:83–93

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Abteilung für antimikrobielle Therapie und Infektionsimmunologie, Kinderklinik der Universität München, Germany

    D. Adam

Authors
  1. D. Adam
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Adam, D. Zur klinischen Bedeutung von Betalaktamase-Inhibitoren. Klin Wochenschr 66, 81–83 (1988). https://doi.org/10.1007/BF01713017

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01713017

Search

Navigation